News

Combination treatment for neovascular age-related macular degeneration is more likely to provide more favorable results by eliminating vascular endothelial growth factor and possibly causing true regression of choroidal neovascularization, reducing the risk of visual loss.

Ocriplasmin achieved complete resolution of vitreomacular adhesion (VMA) in more study patients with VMA and exudative age-related macular degeneration compared with patients in the sham group.

With several options available for improving vision in patients with neovascular age-related macular degeneration, the decision about which agent to use might take into account information on resolution of macular edema, cost, and safety.

The FDA has granted 510(k) clearance to Bausch + Lomb’s femtosecond laser platform (Victus) for the creation of incisions in the cornea of patients undergoing cataract surgery or other ophthalmic treatments requiring incisions in the cornea.

A corneal presbyopia inlay seems to have overcome two obstacles to patient satisfaction by providing good near vision without glare and halos.

Lamellar-perforating keratoplasty is a new excimer laser-assisted transplantation technique developed for eyes with advanced keratoconus.

A switch from bevacizumab to ranibizumab and, in some patients, a subsequent higher dose of ranibizumab, resulted in further improvement for patients with diabetic macular edema in a recent study.

Results from the MIVI-TRUST trials serve as a guide to identifying cases of symptomatic vitreomacular adhesion that are most likely to achieve success with ocriplasmin treatment.

A dexamethasone implant provides long-term visual improvements in patients with diabetic macular edema treated with two doses of the drug.

An ophthalmologist with a practice in Brazil explains how using photothermal stimulation with an algorithm is an effective treatment for his patients with diabetic macular edema and central serous chorioretinopathy.

With a decline in research funding over the years, it is hoped by many that the Affordable Care Act will be the relief needed to keep the field growing and desirable to future ophthalmologists.

Some days I just can’t help feeling great about the future, especially the future of medicine. And then on other days, like today, I watch videos and read stories on the Internet of people being gunned down in the streets of giant “world-class” cities like Kiev, Caracas, Bangkok, and Aleppo by their fellow citizens.

Monthly injections yielded superior vision increases, marked retinal thickness decreases

Retinal imaging is rapidly advancing with the introduction of novel technologies and new imaging techniques.

With the next step in cataract surgery, femtosecond laser-assisted cataract surgery, it is important to education physicians, staff members, and patients on the technology.

Progress in posterior segment optical coherence tomography (OCT) imaging is continuing with novel software that provides better correction for eye motion, as well as new technology which offers faster imaging speeds, said James Fujimoto, PhD.

The John A. Moran Eye Center at the University of Utah announced that Voyant Biotherapeutics-a company formed out of its Center for Translational Medicine (CTM)-has signed an exclusive research and development collaboration agreement with Allergan.

Topcon Medical Laser Systems announced that Daniel Palanker, PhD, has received the International Society for Optics and Photonics’ 2014 Translational Research Award.

The Scottish Medicines Consortium (SMC), after completing its assessment and review of a simple patient access scheme, has accepted Alimera Sciences’ fluocinolone acetonide intravitreal implant (Iluvien) for restricted use within the National Health Service (NHS) Scotland.

A new layer in the human cornea-discovered by researchers at the University of Nottingham last year-has been found to play a vital role in the structure of the tissue that controls the flow of fluid from the eye.

As Bob Costas’ eye infection caused him to step away from his Sochi Olympics reporting duties, the American Academy of Ophthalmology (AAO) is reminding the public of the importance of seeking prompt medical treatment and practicing good hygiene to reduce the spread of what can be highly infectious eye conditions.

Bilateral panuveitis associated with retinal vasculitis has been found to be the most common ocular manifestation-and administration of oral systemic corticosteroids was the most common intervention-according to a 25-year study of the uveitic patterns in Behçet’s disease in Saudi Arabian patients presented by J. Fernando Arevalo, MD.

Nicox S.A. has decided to re-focus its naproxcinod development efforts, granting an undisclosed financial partner the right to enter into a period of exclusive evaluation to assess the potential development of the drug and of next-generation nitric oxide (NO)-donors outside the ophthalmology area.

Bausch + Lomb have announced the U.S. introduction of BLIS (Bausch + Lomb Injector System), designed exclusively for use with the enVista glistening-free, hydrophobic acrylic IOL.

Alan G. Kabat, OD, discusses why olopatadine 0.2% is his preferred anti-allergy medication for managing mild-to-moderate seasonal allergic conjunctivitis.

A surgeon undergoing implantation of a corneal inlay to treat presbyopia enjoys the same visual benefits as his patients with the device.

Numerous clinical trials are under way that may help to define the role of immunotherapy in ocular allergy.

Thorough treatment of the ciliary processes-combined with measures for minimizing postoperative IOP spikes and inflammation-will lead to improved outcomes when performing endoscopic cyclophotocoagulation with cataract surgery.

Percutaneous ablation of lymphatic malformations is a safe, effective alternative to surgical resection, based on extensive follow-up of a large series of cases performed at a leading pediatric hospital in the United States.

Long-term trial data for a small-aperture corneal inlay (Kamra, AcuFocus) for presbyopia turned in superb results.